These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9520144)
1. Evidence of ABC transporters in fresh tumor cells from patients with ovarian cancer. Sargent JM; Coley HM; Williamson C; Taylor C Int J Clin Pharmacol Ther; 1998 Feb; 36(2):64-6. PubMed ID: 9520144 [No Abstract] [Full Text] [Related]
2. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells. Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353 [TBL] [Abstract][Full Text] [Related]
3. Monitoring of cellular resistance to cancer chemotherapy. Krishan A; Arya P Hematol Oncol Clin North Am; 2002 Apr; 16(2):357-72, vi. PubMed ID: 12094476 [TBL] [Abstract][Full Text] [Related]
4. Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer. Szaflarski W; Sujka-Kordowska P; Pula B; Jaszczyńska-Nowinka K; Andrzejewska M; Zawierucha P; Dziegiel P; Nowicki M; Ivanov P; Zabel M Int J Oncol; 2013 Aug; 43(2):513-20. PubMed ID: 23739867 [TBL] [Abstract][Full Text] [Related]
5. The role of breast cancer resistance protein in acute lymphoblastic leukemia. Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques. Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006 [TBL] [Abstract][Full Text] [Related]
7. Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in Golgi vesicles. Merlin JL; Bour-Dill C; Marchal S; Ramacci C; Poullain MG; Giroux B Cytometry; 2000 Sep; 41(1):62-72. PubMed ID: 10942898 [TBL] [Abstract][Full Text] [Related]
8. Drug retention, efflux, and resistance in tumor cells. Krishan A; Fitz CM; Andritsch I Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409 [TBL] [Abstract][Full Text] [Related]
9. Coexpression of multidrug resistance involve proteins: a flow cytometric analysis. Boutonnat J; Bonnefoix T; Mousseau M; Seigneurin D; Ronot X Anticancer Res; 1998; 18(4C):2993-9. PubMed ID: 9713498 [TBL] [Abstract][Full Text] [Related]
10. Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma. Arts HJ; Katsaros D; de Vries EG; Massobrio M; Genta F; Danese S; Arisio R; Scheper RJ; Kool M; Scheffer GL; Willemse PH; van der Zee AG; Suurmeijer AJ Clin Cancer Res; 1999 Oct; 5(10):2798-805. PubMed ID: 10537344 [TBL] [Abstract][Full Text] [Related]
11. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance. Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575 [TBL] [Abstract][Full Text] [Related]
12. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts. Kolfschoten GM; Hulscher TM; Pinedo HM; Boven E Br J Cancer; 2000 Oct; 83(7):921-7. PubMed ID: 10970695 [TBL] [Abstract][Full Text] [Related]
13. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. Sugawara I; Akiyama S; Scheper RJ; Itoyama S Cancer Lett; 1997 Jan; 112(1):23-31. PubMed ID: 9029166 [TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines. van der Pol JP; Blom DJ; Flens MJ; Luyten GP; de Waard-Siebinga I; Koornneef L; Scheper RJ; Jager MJ Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2523-30. PubMed ID: 9375571 [TBL] [Abstract][Full Text] [Related]
15. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells. Gollapudi S; Kim CH; Tran BN; Sangha S; Gupta S Cancer Chemother Pharmacol; 1997; 40(2):150-8. PubMed ID: 9182837 [TBL] [Abstract][Full Text] [Related]
16. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Modok S; Mellor HR; Callaghan R Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355 [TBL] [Abstract][Full Text] [Related]
17. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia. Ho MM; Hogge DE; Ling V Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061 [TBL] [Abstract][Full Text] [Related]
18. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells. Mo L; Pospichalova V; Huang Z; Murphy SK; Payne S; Wang F; Kennedy M; Cianciolo GJ; Bryja V; Pizzo SV; Bachelder RE PLoS One; 2015; 10(7):e0131579. PubMed ID: 26148191 [TBL] [Abstract][Full Text] [Related]
19. Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs. Aszalos A; Ross DD Anticancer Res; 1998; 18(4C):2937-44. PubMed ID: 9713488 [TBL] [Abstract][Full Text] [Related]
20. [Multidrug resistance of cancer cells mediated by ABC superfamily transporters]. Ueda K Nihon Rinsho; 1997 May; 55(5):1024-9. PubMed ID: 9155147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]